Keep R F, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets[J]. Lancet Neurol, 2012, 11(8): 720-731.？ [2]罗丹, 李芳芳, 王啸, 等. 自发性脑出血患者并发症的相关危险因素分析[J]. 第三军医大学学报, 2012, 34(14): 1438-1441.？ [3]朱孔江, 徐广振, 杨辉. 小鼠脑出血模型血肿周围雌激素受体的表达[J]. 第三军医大学学报, 2013, 35(17): 1877-1879. [4]Zhou Y, Wang Y, Wang J, et al. Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation[J]. Prog Neurobiol, 2014, 115: 25-44.？ [5]Mendelow A D, Gregson B A, Rowan E N, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH Ⅱ): a randomised trial[J]. Lancet, 2013, 382(9890): 397-408.？ [6]Silverstein R L, Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior[J]. Sci Signal, 2009, 2(72): re3.？ [7]Silverstein R L. Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36[J]. Cleve Clin J Med, 2009, 76 Suppl 2: S27-S30. [8]Zhao X, Sun G, Zhang J, et al. Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages[J]. Ann Neurol, 2007, 61(4): 352-362.？ [9]Sansing L H, Harris T H, Welsh F A, et al. Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage[J]. Ann Neurol, 2011, 70(4): 646-656. [10]Fang H, Chen J, Lin S, et al. CD36-mediated hematoma absorption following intracerebral hemorrhage: negative regulation by TLR4 signaling[J]. J Immunol, 2014, 192(12): 5984-5992.？ [11]Steiner T, Kaste M, Forsting M, et al. Recommendations for the management of intracranial haemorrhage—part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee[J]. Cerebrovasc Dis, 2006, 22(4): 294-316.？ [12]Gao L, Zhao H, Liu Q, et al. Improvement of hematoma absorption and neurological function in patients with acute intracerebral hemorrhage treated with Xueshuantong[J]. J Neurol Sci, 2012, 323(1/2): 236-240.？ [13]Aitman T J. CD36, insulin resistance, and coronary heart disease[J]. Lancet, 2001, 357(9257): 651-652.？ [14]李大成, 蓝欲晓, 鲍自谦, 等. 深圳地区无偿献血者群体CD36抗原缺失型的表型分析[J]. 中国输血杂志, 2012, 25(4): 304-307.？ [15]刘凌, 叶刚强, 李流娇, 等. 肇庆地区普通人群血小板基因HPA1-6和15基因多态性及CD36抗原缺失分析[J]. 广东医学,？ 2013, 34(13): 2054-2056.？ [16]Li R, Qiao Z, Ling B, et al. Incidence and molecular basis of CD36 deficiency in Shanghai population[J]. Transfusion, 2015, 55(3): 666-673.？ [17]Xu X, Ye X, Xia W, et al. Studies on CD36 deficiency in South China: two cases demonstrating the clinical impact of anti-CD36 antibodies[J]. Thromb Haemost, 2013, 110(6): 1199-1206.
